These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39241761)

  • 1. Ping, pong, and freeze: Structural insights into the inhibition of ceramide synthase by Fumonisin B1.
    Hu K; Cao Y
    Structure; 2024 Sep; 32(9):1296-1298. PubMed ID: 39241761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of ceramide synthase inhibition by fumonisin B
    Zhang Z; Fang Q; Xie T; Gong X
    Structure; 2024 Sep; 32(9):1419-1428.e4. PubMed ID: 38964337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of N-acyl-fumonisin B1 as new cytotoxic metabolites of fumonisin mycotoxins.
    Harrer H; Laviad EL; Humpf HU; Futerman AH
    Mol Nutr Food Res; 2013 Mar; 57(3):516-22. PubMed ID: 23281112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Fumonisin B1 Toxicity: A Computational Perspective beyond the Ceramide Synthases Inhibition.
    Dellafiora L; Galaverna G; Dall'Asta C
    Chem Res Toxicol; 2018 Nov; 31(11):1203-1212. PubMed ID: 30346146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites.
    Seiferlein M; Humpf HU; Voss KA; Sullards MC; Allegood JC; Wang E; Merrill AH
    Mol Nutr Food Res; 2007 Sep; 51(9):1120-30. PubMed ID: 17729221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Protection against the Sphingolipid Biosynthesis Inhibitor Fumonisin B
    Janevska S; Ferling I; Jojić K; Rautschek J; Hoefgen S; Proctor RH; Hillmann F; Valiante V
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor.
    Humpf HU; Schmelz EM; Meredith FI; Vesper H; Vales TR; Wang E; Menaldino DS; Liotta DC; Merrill AH
    J Biol Chem; 1998 Jul; 273(30):19060-4. PubMed ID: 9668088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae.
    Schorling S; Vallée B; Barz WP; Riezman H; Oesterhelt D
    Mol Biol Cell; 2001 Nov; 12(11):3417-27. PubMed ID: 11694577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.
    Riley RT; Merrill AH
    J Lipid Res; 2019 Jul; 60(7):1183-1189. PubMed ID: 31048407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The revelation of selective sphingolipid pathway inhibition mechanism on fumonisin toxin binding to ceramide synthases in susceptible organisms and survival mechanism in resistant species.
    Sharma S; Ahmed M; Akhter Y
    Biochimie; 2018 Jun; 149():41-50. PubMed ID: 29625159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds.
    van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC
    Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity, kinetic properties and inhibition by fumonisin B1 of ceramide synthase isoforms from Arabidopsis.
    Luttgeharm KD; Cahoon EB; Markham JE
    Biochem J; 2016 Mar; 473(5):593-603. PubMed ID: 26635357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
    Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Arabidopsis Ceramide Synthases Differentially Affects Growth, Sphingolipid Metabolism, Programmed Cell Death, and Mycotoxin Resistance.
    Luttgeharm KD; Chen M; Mehra A; Cahoon RE; Markham JE; Cahoon EB
    Plant Physiol; 2015 Oct; 169(2):1108-17. PubMed ID: 26276842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Fumonisin Self-Resistance:
    Krska T; Twaruschek K; Wiesenberger G; Berthiller F; Adam G
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922130
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of lipid biosynthesis in Saccharomyces cerevisiae by fumonisin B1.
    Wu WI; McDonough VM; Nickels JT; Ko J; Fischl AS; Vales TR; Merrill AH; Carman GM
    J Biol Chem; 1995 Jun; 270(22):13171-8. PubMed ID: 7768913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
    Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lip1p: a novel subunit of acyl-CoA ceramide synthase.
    Vallée B; Riezman H
    EMBO J; 2005 Feb; 24(4):730-41. PubMed ID: 15692566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo formation of N-acyl-fumonisin B1.
    Harrer H; Humpf HU; Voss KA
    Mycotoxin Res; 2015 Feb; 31(1):33-40. PubMed ID: 25326150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.